KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Takeda Pharmaceutical (TAK) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $0.88.

  • Takeda Pharmaceutical's Shares Outstanding (Diluted Average) rose 134.94% to $0.88 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.88, marking a year-over-year increase of 134.94%. This contributed to the annual value of $0.44 for FY2025, which is 3017.8% down from last year.
  • According to the latest figures from Q4 2025, Takeda Pharmaceutical's Shares Outstanding (Diluted Average) is $0.88, which was up 134.94% from $0.48 recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Shares Outstanding (Diluted Average) registered a high of $2.26 during Q1 2021, and its lowest value of $0.18 during Q3 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $0.78 (2022), whereas its average is $0.85.
  • In the last 5 years, Takeda Pharmaceutical's Shares Outstanding (Diluted Average) surged by 77010.28% in 2021 and then plummeted by 7647.62% in 2023.
  • Takeda Pharmaceutical's Shares Outstanding (Diluted Average) (Quarter) stood at $1.35 in 2021, then dropped by 3.97% to $1.29 in 2022, then tumbled by 51.25% to $0.63 in 2023, then skyrocketed by 37.43% to $0.87 in 2024, then increased by 1.35% to $0.88 in 2025.
  • Its last three reported values are $0.88 in Q4 2025, $0.48 for Q3 2025, and $0.54 during Q2 2025.